Moon Shot Lecture Introduction
Breast and Ovarian Cancers Moon Shot Lecture
Presenter: Anil K. Sood, M.D.
Professor, Gynecologic Oncology and Reproductive Medicine
Summary: Triple-negative breast cancer (TNBC) is considered one of the most deadly types of breast cancer. The survival rate is only 60%, compared to more than 80% for all other breast cancer subtypes. High-grade serous ovarian cancer (HGSOC) is an aggressive subtype which causes nearly 90% of ovarian cancer deaths. Researchers have discovered that patients with high-grade serous ovarian cancer and patients with triple-negative breast cancer have common molecular and biological alterations. This genetic link drives The University of Texas MD Anderson Cancer Center’s novel, unified research effort, the Breast and Ovarian Cancers Moon Shot, which is defining new therapeutic opportunities for these deadly types of cancer.
“Patients with high-grade serous or triple-negative breast cancer have many common genetic alterations that place them at risk for cancer formation,” says Anil K. Sood, MD, Professor of Gynecologic Oncology & Reproductive Medicine at The University of Texas MD Anderson Cancer Center. In this lecture, Sood explains the goals of MD Anderson’s combined “Breast and Ovarian Cancers Moon Shot.” He defines the unmet needs of patients with high-grade serous ovarian cancer and triple-negative breast cancer. He articulates the goals of primary cytoreductive or debulking surgery and explains and advises on how to best implement a new MD Anderson Algorithm into clinical practice.
For further information or assistance, to provide feedback on this web site, or to request a specific professional oncology education topic, please e-mail Professional Oncology Education.